Furthermore, it has been demonstrated that KAT2A expression is elevated in CRC, and the knockdown of KAT2A has been shown to reduce the proliferation and migration of CRC cell lines [11, 54]. The gene discussed is KAT2A; the disease is colorectal carcinoma.